Curis
CRIS
#11190
Rank
ยฃ1.23 M
Marketcap
ยฃ0.51
Share price
-5.38%
Change (1 day)
-57.93%
Change (1 year)

Curis (CRIS) - Net assets

Net assets on the balance sheet as of June 2026 : ยฃ3.54 Million

According to Curis's latest financial reports the company has ยฃ3.54 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Curis - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$ยฃ4.05 M-184.86%
2024-12-31$-ยฃ4.78 Million-130.96%
2023-12-31$ยฃ15.43 M-59.88%
2022-12-31$ยฃ38.47 M-42.74%
2021-12-31$ยฃ67.19 M-29.9%
2020-12-31$ยฃ95.86 M-470.7%
2019-12-31$-ยฃ25.87 Million630.12%
2018-12-31$-ยฃ3.55 Million-119.95%
2017-12-31$ยฃ17.75 M-25.15%
2016-12-31$ยฃ23.71 M-45.51%
2015-12-31$ยฃ43.53 M127.56%
2014-12-31$ยฃ19.13 M-30.15%
2013-12-31$ยฃ27.38 M29.17%
2012-12-31$ยฃ21.2 M-17.36%
2011-12-31$ยฃ25.65 M-12.99%
2010-12-31$ยฃ29.48 M44.36%
2009-12-31$ยฃ20.42 M-19.58%
2008-12-31$ยฃ25.39 M7.71%
2007-12-31$ยฃ23.58 M28.67%
2006-12-31$ยฃ18.32 M-16.83%
2005-12-31$ยฃ22.03 M-12.44%
2004-12-31$ยฃ25.16 M15.83%
2003-12-31$ยฃ21.72 M87.88%
2002-12-31$ยฃ11.56 M-83.4%
2001-12-31$ยฃ69.67 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
ยฃ64.60 B 1,820,815.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ16.86 B 475,278.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
ยฃ20.25 M 470.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
ยฃ1.39 B 39,170.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
ยฃ0.53 B 15,119.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
ยฃ8.27 M 133.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.25 B 7,171.57%๐Ÿ‡บ๐Ÿ‡ธ USA